FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
HCG
128.15
+1.25 (0.99%)
Updated 03:29 04/08 IST
HCG Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for HCG
Disclaimer0% Bullish
0% Bearish
HCG Buy or Sell - Brokerage Reports
No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
HCG Ratings
Long term HCG rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
0/5 (0 Ratings)0
Find answers to all your questions on live HCG message board: Is HCG buy or sell? Should I buy HCG shares? Why are HCG shares falling? Should I invest in HCG stock?
- Home
- HCG Forum
HCG Share Price Discussion
N
Reputation: 4,059 • Jul 15 2:46 AM
CCI approves Aceso's acquisition of 58.92% stake in HealthCare Global Enterprises - The Economic Times
In a tweet, the Competition Commission of India (CCI) said it "approves acquisition of upto 58.92% stake of HealthCare Global Enterprises Limited by Aceso Company Pte. Ltd."
In a tweet, the Competition Commission of India (CCI) said it "approves acquisition of upto 58.92% stake of HealthCare Global Enterprises Limited by Aceso Company Pte. Ltd."
The Economic Times
Like
Reply
N
Reputation: 4,059 • Jun 4 3:23 AM
Deals of the day: BNP Paribas sells stake in RBL Bank; Fidelity offloads shares of SH Kelkar
Fidelity Investment Trust's Fidelity Series Emerging Markets Fund sold 8,10,800 shares of SH Kelkar at an average price of Rs 65.24 per share
Fidelity Investment Trust's Fidelity Series Emerging Markets Fund sold 8,10,800 shares of SH Kelkar at an average price of Rs 65.24 per share
Moneycontrol
Like
Reply
N
Reputation: 4,059 • May 19 2:53 AM
Trade Setup for Wednesday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 8,812.82, followed by 8,746.53. If the index moves up, key resistance levels to watch out for are 8,987.87 and 9,096.63.
Key support level for Nifty is placed at 8,812.82, followed by 8,746.53. If the index moves up, key resistance levels to watch out for are 8,987.87 and 9,096.63.
Moneycontrol
Like
Reply
S
Reputation: 36,504 • May 17 8:56 AM
IDFC Securities - Healthcare Global Enterprises (HCG) HealthCare Global Enterprises Q3FY20 results (Outperformer) - Capex cycle nears an end
Q3FY20 result highlights Revenues grew by 12% yoy to Rs2.78bn below est of Rs2.86bn with HCG centres posting 12% growth yoy. Milann centres grew 8.6% yoy. EBITDA stood higher at Rs457m. Adjusting
Q3FY20 result highlights Revenues grew by 12% yoy to Rs2.78bn below est of Rs2.86bn with HCG centres posting 12% growth yoy. Milann centres grew 8.6% yoy. EBITDA stood higher at Rs457m. Adjusting
ResearchPool
*Breaking News: Buena Vista Asia Opportunities Fund acquires 28.76 lakh shares (3.25%). Upside possible
*HCG will be rerated as CVC acquiring Majority stake @Rs 120*
Like
Reply
S
Reputation: 36,504 • May 14 7:58 AM
IDFC Securities - Healthcare Global Enterprises (HCG) HealthCare Global Enterprises Q3FY20 results (Outperformer) - Capex cycle nears an end
Q3FY20 result highlights Revenues grew by 12% yoy to Rs2.78bn below est of Rs2.86bn with HCG centres posting 12% growth yoy. Milann centres grew 8.6% yoy. EBITDA stood higher at Rs457m. Adjusting
Q3FY20 result highlights Revenues grew by 12% yoy to Rs2.78bn below est of Rs2.86bn with HCG centres posting 12% growth yoy. Milann centres grew 8.6% yoy. EBITDA stood higher at Rs457m. Adjusting
ResearchPool
*Breaking News: Buena Vista Asia Opportunities Fund acquires 28.76 lakh shares (3.25%). 90% upside Possible. TP 165*
*HCG will be rerated as CVC acquiring Majority stake @Rs 120*
Like
Reply
N
Reputation: 4,059 • Apr 21 5:38 AM
Don’t expect fireworks in Q4, but these 10 stocks may double profit YoY
Consumer/Private Banks (benefit of low base)/ Healthcare is expected to be the key outperformers this quarter, and all the key matrices are expected to post multi-quarter low growth figures.
Consumer/Private Banks (benefit of low base)/ Healthcare is expected to be the key outperformers this quarter, and all the key matrices are expected to post multi-quarter low growth figures.
Moneycontrol
Like
Reply
N
Reputation: 4,059 • Mar 25 9:43 AM
Lockdown, social distancing, visa cancellations to hit hospital earnings
As the situation remains uncertain, the sector is likely to remain under pressure over short to medium term, says Edelweiss.
As the situation remains uncertain, the sector is likely to remain under pressure over short to medium term, says Edelweiss.
Moneycontrol
Like
Reply
I
Reputation: 2,343 • Dec 17, 2019 10:37 AM
HCG to divest fertility division, focuses on tightening costs,paring debt Fertility division contributed about 6.6 percent of the HCG consolidated revenue of Rs 978.7 crore in FY19.
Like
Reply
N
Reputation: 4,059 • Aug 13, 2019 3:43 AM
Q1 impact: Brokerages upgrade these 10 stocks, expect double digit returns
Thunuguntla said stocks in non-banking sectors have been languishing that reflects the impact of a slow economy
Thunuguntla said stocks in non-banking sectors have been languishing that reflects the impact of a slow economy
www.moneycontrol.com
Like
Reply
N
Reputation: 4,059 • Aug 8, 2019 12:08 PM
Healthcare Glob Standalone June 2019 Net Sales at Rs 170.89 crore, up 10.85% Y-o-Y
moneycontrol.com
Like
Reply
N
Reputation: 4,059 • Jul 18, 2019 3:28 AM
Red signal: These 10 companies may report loss in June quarter earnings
Like
Reply
N
Reputation: 4,059 • Jul 12, 2019 3:43 AM
These 10 stocks are likely to report over 100% YoY growth in PAT in Q1FY20
Like
Reply
N
Reputation: 4,059 • Jun 26, 2019 1:53 AM
Stocks in the news: Mindtree, DHFL, Aptech, ICICI Lombard, Adani Power, NTPC
Like
Reply
N
Reputation: 4,059 • May 23, 2019 11:53 AM
Healthcare Glob Standalone March 2019 Net Sales at Rs 165.93 crore, up 8.77% Y-o-Y
Like
Reply
N
Reputation: 4,059 • Feb 28, 2019 9:47 AM
No nation has ever prospered by putting price control: BS Ajaikumar, Healthcare Global
Like
Reply
N
Reputation: 4,059 • Feb 8, 2019 1:42 AM
Stocks in the news: Tata Motors | Fortis Health | Jet Airways | Aurobindo Pharma | Varun Beverages | BPCL | Tata Steel
https://www.moneycontrol.com/news/business/markets/stocks-in-the-news-tata-motors-fortis-health-jet-airways-aurobindo-pharma-varun-beverages-bpcl-tata-steel-3500...
Read more...
Like
Reply
N
Reputation: 4,059 • Feb 7, 2019 11:32 AM
Healthcare Glob Standalone December 2018 Net Sales at Rs 159.67 crore, up 12.37% Y-o-Y
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
HCG Share Price - Technicals
- NewsBotJul 15 2:46 AMCCI approves Aceso's acquisition of 58.92% stake in HealthCare Global Enterprises - The Economic TimesThe Economic TimesNewsBotJun 4 3:23 AMDeals of the day: BNP Paribas sells stake in RBL Bank; Fidelity offloads shares of SH KelkarMoneycontrolNewsBotApr 21 5:38 AMDon’t expect fireworks in Q4, but these 10 stocks may double profit YoYMoneycontrolNewsBotMar 25 9:43 AMLockdown, social distancing, visa cancellations to hit hospital earningsMoneycontrolNewsBotAug 13, 2019 3:43 AMQ1 impact: Brokerages upgrade these 10 stocks, expect double digit returnswww.moneycontrol.comNewsBotAug 8, 2019 12:08 PMHealthcare Glob Standalone June 2019 Net Sales at Rs 170.89 crore, up 10.85% Y-o-Ymoneycontrol.comNewsBotJul 18, 2019 3:28 AMRed signal: These 10 companies may report loss in June quarter earningsNewsBotJul 12, 2019 3:43 AMThese 10 stocks are likely to report over 100% YoY growth in PAT in Q1FY20NewsBotJun 26, 2019 1:53 AMStocks in the news: Mindtree, DHFL, Aptech, ICICI Lombard, Adani Power, NTPCNewsBotMay 23, 2019 11:53 AMHealthcare Glob Standalone March 2019 Net Sales at Rs 165.93 crore, up 8.77% Y-o-Y
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.